drugset / Trial / NCT03341169

Impact of Perioperative Treatment With Intravenous Glutamine on Myocardial Protection in Cardiac Surgery Patients With Aortic Stenosis

NCT03341169 ↗

Unknown 108 enrolled Yonsei University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to confirm if myocardial protection effect can be obtained by intravenous administration of glutamine in patients undergoing aortic valve replacement with severe aortic stenosis (who are at high risk for ischemia-reperfusion injury). As a prospective double blinded randomized placebo-controlled trial, the investigators detect and compare the degree of myocardial damage(with CK-MB and Troponin T) and myocardial protection (through hsp 70 expression in atrial tissue), cardiovascular index, inflammatory reaction, and clinical manifestation.

Timeline

Start
2018-03-20
Primary completion
2019-09-28
Completion
2019-09-28

Drugs

EvaluationDrugModalityDoseRoute
Subject N(2)-L-Alanine L-Glutamine dipeptide Peptide 0.25 g/kg Intravenous

Indications